Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma (Q38711061)

5 September 2017

title

Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma (English)

1 reference

5 September 2017

1 reference

Libing Fu

1

1 reference

5 September 2017

Yaqiong Jin

2

1 reference

5 September 2017

Chao Jia

3

1 reference

5 September 2017

Jie Zhang

4

1 reference

5 September 2017

Jun Tai

5

1 reference

5 September 2017

Hongbin Li

6

1 reference

5 September 2017

Feng Chen

7

1 reference

5 September 2017

Jin Shi

8

1 reference

5 September 2017

Yongli Guo

9

1 reference

5 September 2017

Xin Ni

10

1 reference

5 September 2017

Lejian He

11

1 reference

5 September 2017

publication date

16 June 2017

1 reference

Science in China. Series C: Life Sciences

5 September 2017

published in

1 reference

5 September 2017

volume

60

1 reference

5 September 2017

issue

7

1 reference

5 September 2017

page(s)

721-728

1 reference

describes a project that uses

5 September 2017

fluorescence in situ hybridization

1 reference

based on heuristic

inferred from title

cites work

Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Current chemotherapeutic strategies for rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Genomic Characterization of a Metastatic Alveolar Rhabdomyosarcoma Case Using FISH Studies and CGH+SNP Microarray Revealing FOXO1-PAX7 Rearrangement with MYCN and MDM2 Amplification and RB1 Region Loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Pathologic classification of rhabdomyosarcomas and correlations with molecular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Childhood rhabdomyosarcoma: recent advances and prospective views

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-017-9082-9

10.1007/S11427-017-9082-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1086122256

0 references

1 reference